SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K, dated August 6, 2024, serves as a current report for National Health Investors Inc, a Maryland corporation. The filing primarily functions to disclose supplemental information regarding the quarter ended June 30, 2024, pursuant to Regulation FD (Item 7.01). The company's common stock trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The filing text itself does not contain specific financial data points such as revenue, profit, cash flow, margins, debt, or liquidity figures. These metrics are referenced as being contained within "Supplemental Information" provided in Exhibit 99.1, which is hosted on the company's website but not included in the text of this 8-K summary.
Material Changes
No material changes to financial performance or operations are detailed within the body of this specific filing. The document acts as a conduit to direct investors to the supplemental data for the quarter ended June 30, 2024.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary, risk factors, or details on contingencies. It strictly references the existence of supplemental information for the reported quarter.
Key Facts for Investor Verification
- Verify the specific financial metrics (revenue, FFO, debt levels) by accessing Exhibit 99.1 on the company's website (www.nhireit.com) as referenced in Item 7.01.
- Confirm the reporting period covered by the supplemental data is the quarter ended June 30, 2024.
- Note that this 8-K filing is a disclosure mechanism and does not contain the underlying financial tables or narrative analysis.